Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
The Journal of Biological Chemistry|July 1, 2010
A novel pleckstrin homology domain-containing protein enhances insulin-stimulated Akt phosphorylation and GLUT4 translocation in adipocytesQiong L Zhou, Zhen Y Jiang, Allan S Mabardy, et al.
Revista De Neurologia|March 1, 2005
[Large-scale genotyping in research into autism spectrum disorders and attention deficit hyperactivity disorder]M Bayés, J A Ramos, B Cormand, et al.
American Journal of Medical Genetics|July 16, 1999
Albinism and agenesis of the corpus callosum with profound developmental delay: Vici syndrome, evidence for autosomal recessive inheritanceM del Campo, B D Hall, A Aeby, et al.
Cancer|October 16, 2013
Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: results of a randomized, double-blind, phase 2, parallel-arm studyWilliam P Tew, Nicoletta Colombo, Isabelle Ray-Coquard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatinG B Kristensen, I Vergote, G Stuart, et al.
Cellular and Molecular Life Sciences : CMLS|October 23, 2014
BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cellsM Del Campo, C R Oliveira, W Scheper, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|March 11, 2006
[Clinical guide to the management of patients with Beckwith-Wiedemann syndrome]P Lapunzina Badía, M del Campo Casanelles, A Delicado Navarro, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 9, 2011
Feasibility of a modified outpatient regimen of intravenous/intraperitoneal chemotherapy in optimally debulked stage III ovarian cancer patients: a GEICO studyAna Oaknin, Desamparado Roda, Antonio González-Martín, et al.
Immunity|October 9, 2016
Reversed T Cell Receptor Docking on a Major Histocompatibility Class I Complex Limits Involvement in the Immune ResponseStephanie Gras, Jesseka Chadderton, Claudia M Del Campo, et al.
Magma (New York, N.Y.)|January 5, 2011
A Bayesian hierarchical model for DCE-MRI to evaluate treatment response in a phase II study in advanced squamous cell carcinoma of the head and neckBrandon Whitcher, Volker J Schmid, David J Collins, et al.
Pageof 17